Capital Rx, a pharmacy benefit manager in the United States, announced yesterday that it has named Josh Golden as its new senior vice president of Strategy.
Golden has more than a decade of experience as a strategic consultant in the healthcare industry. He will evaluate market trends, assess business initiatives, and develop strategic partnerships to support Capital Rx's continued growth.
Earlier, Golden served as area senior vice president at Solid Benefit Guidance. Prior to joining Solid Benefit Guidance in 2016, he was the practice leader for the Employer Consulting Segment of Pharmaceutical Strategies Group LLC. He has also held strategic consulting positions at Aon Hewitt, Mercer Human Resource Consulting, and Buck Consultants.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business